BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
BioWorld 2024 review
BioWorld MedTech 2024 review
BioWorld Science 2024 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Monday, January 6, 2025
Home
»
Topics
»
Disease categories and therapies
» Endocrine/metabolic
Endocrine/metabolic
RSS
Novartis files for U.S. marketing approval of Sandostatin LAR
June 3, 1998
No Comments
New Lilly compounds for postmenopausal syndrome
June 3, 1998
No Comments
Inhibitors of cysteine protease from SKB for bone and cartilage disorders
June 3, 1998
No Comments
Patient enrollment complete for RII retinamide phase I/II trial
June 3, 1998
No Comments
Research demonstrates vital role of hMSCs in hematopoiesis
June 2, 1998
No Comments
Potent new cholesterol biosynthesis inhibitors reported by Novartis
June 2, 1998
No Comments
Theratechnologies' GRF analogues receive patent coverage
June 2, 1998
No Comments
SR-146131, the most potent CCK-A receptor agonist reported to date
June 2, 1998
No Comments
Novartis and Trega sign agreement for obesity and diabetes research
June 1, 1998
No Comments
Compounds for bone diseases, neuropathy discovered at Takeda
June 1, 1998
No Comments
Previous
1
2
…
1642
1643
1644
1645
1646
1647
1648
1649
1650
…
1793
1794
Next